Variant report
Variant | nsv1024274 |
---|---|
Chromosome Location | chr9:1496424-1514379 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr9:1492000..1494748-chr9:1498884..1501267,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs557765544 | chr9:1496460-1496461 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs548641295 | chr9:1496505-1496506 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs540767846 | chr9:1496517-1496518 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs559234419 | chr9:1496520-1496521 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs73640482 | chr9:1496529-1496530 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs541721797 | chr9:1496549-1496550 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs562034157 | chr9:1496554-1496555 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs142363764 | chr9:1496564-1496565 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs4740591 | chr9:1496571-1496572 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs76750690 | chr9:1496581-1496582 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs76580917 | chr9:1496585-1496586 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs7850035 | chr9:1496606-1496607 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs374829144 | chr9:1496618-1496619 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs78609823 | chr9:1496635-1496636 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs116405342 | chr9:1496643-1496644 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs188920847 | chr9:1496664-1496665 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs1999436 | chr9:1496686-1496687 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs7865917 | chr9:1496693-1496694 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs7850059 | chr9:1496696-1496697 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs150839788 | chr9:1496698-1496699 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs557726610 | chr9:1496729-1496730 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs577617963 | chr9:1496742-1496743 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs369708220 | chr9:1496754-1496755 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs139939034 | chr9:1496755-1496756 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs370874725 | chr9:1496781-1496782 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs554254062 | chr9:1496828-1496829 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs572920801 | chr9:1496833-1496834 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs541984458 | chr9:1496858-1496859 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs77690406 | chr9:1496877-1496878 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs575608495 | chr9:1496912-1496913 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs7851244 | chr9:1496915-1496916 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs78926518 | chr9:1496916-1496917 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs532961630 | chr9:1496917-1496918 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs372423335 | chr9:1496920-1496921 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs560171856 | chr9:1496937-1496938 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs192538311 | chr9:1496960-1496961 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs549546198 | chr9:1496965-1496966 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs569153519 | chr9:1496968-1496969 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs538101343 | chr9:1496993-1496994 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs76380780 | chr9:1496997-1496998 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs571271563 | chr9:1497003-1497004 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs534217252 | chr9:1497009-1497010 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs564580397 | chr9:1497019-1497020 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs533431594 | chr9:1497021-1497022 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs550416047 | chr9:1497024-1497025 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs150145038 | chr9:1497025-1497026 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs79682140 | chr9:1497031-1497032 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs143371209 | chr9:1497032-1497033 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs570239001 | chr9:1497045-1497046 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs535804123 | chr9:1497046-1497047 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ovarian cancer | 21720365 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Melanoma | 18172304 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Williams-beuren syndrome | 18553513 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Pilocytic astrocytoma | 18622384 | CNVD |
Pilomyxoid astrocytoma | 18622384 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
prenatal diagnosis | 20453657 | CNVD |
Gastric cancer | 16715143 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Disorders of sex development | 22290220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21183584 | CNVD |
Non-small cell lung cancer | 21952639 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Intellectual disability | 22102821 | CNVD |
abnormal development | 18461090 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 20531469 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21785460 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:1491000-1504000 | Weak transcription | Adipose Nuclei | Adipose |
2 | chr9:1496800-1497000 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
3 | chr9:1497000-1497200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr9:1504000-1504800 | Strong transcription | Adipose Nuclei | Adipose |
5 | chr9:1504800-1513800 | Weak transcription | Adipose Nuclei | Adipose |
6 | chr9:1511000-1511200 | Enhancers | NHEK | skin |
7 | chr9:1512600-1513000 | Enhancers | Fetal Muscle Leg | muscle |
8 | chr9:1512800-1514200 | Enhancers | NHEK | skin |
9 | chr9:1513000-1513400 | Weak transcription | Fetal Muscle Leg | muscle |
10 | chr9:1513000-1513800 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
11 | chr9:1513200-1514000 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
12 | chr9:1513400-1514800 | Enhancers | Fetal Muscle Leg | muscle |
13 | chr9:1513800-1514600 | Enhancers | Adipose Nuclei | Adipose |
14 | chr9:1514000-1514800 | Enhancers | Psoas Muscle | Psoas |